Ritter Pharmaceuticals Announces Last Patient Last Visit in its Phase 3 “Liberatus” Clinical Trial of RP-G28 for Lactose Intolerance

July 2, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search